Improved Insulin Sensitivity With Angiotensin Receptor Neprilysin Inhibition in Individuals With Obesity and Hypertension

J. Jordan*, R. Stinkens, T. Jax, S. Engeli, E. E. Blaak, M. May, B. Havekes, C. Schindler, D. Albrecht, P. Pal, T. Heise, G. H. Goossens, T. H. Langenickel

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)254-263
Number of pages10
JournalClinical Pharmacology & Therapeutics
Volume101
Issue number2
DOIs
Publication statusPublished - Feb 2017

Keywords

  • HEART-FAILURE
  • LIPOLYSIS
  • LCZ696
  • METABOLISM
  • EFFICACY
  • ADIPOSE
  • HUMANS
  • SYSTEM
  • RISK
  • MEN

Cite this

Jordan, J., Stinkens, R., Jax, T., Engeli, S., Blaak, E. E., May, M., Havekes, B., Schindler, C., Albrecht, D., Pal, P., Heise, T., Goossens, G. H., & Langenickel, T. H. (2017). Improved Insulin Sensitivity With Angiotensin Receptor Neprilysin Inhibition in Individuals With Obesity and Hypertension. Clinical Pharmacology & Therapeutics, 101(2), 254-263. https://doi.org/10.1002/cpt.455